0
Skip to Content
MCM6
Science
Pipeline
About
Team
Updates
Contact
MCM6
Science
Pipeline
About
Team
Updates
Contact
Science
Pipeline
About
Team
Updates
Contact
MCM6 logo

Science

About

Pipeline

Updates

Team

Contact

MCM6 is developing disease-modifying therapeutics for APOE4 carriers, the largest patient population at genetic risk for Alzheimer’s disease.

info@mcm6.com

Lexington, MA, U.S.A.

Copyright © MCM6. All rights reserved.